Patents by Inventor Yefet Gamlieli

Yefet Gamlieli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6767466
    Abstract: A filter unit for removing leukocytes from a leukocyte-containing suspension by passing the suspension through a filter unit. The filter unit may comprise a main filter for blocking the leukocytes and a post-filter for preventing leakage of the leukocytes having a higher median pore size than the main filter and placed downstream of the main-filter.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: July 27, 2004
    Assignee: Teva Medical Ltd.
    Inventors: Menahem Kraus, Yefet Gamlieli
  • Publication number: 20040055949
    Abstract: There is provided a leukocyte filter comprising: a prefilter portion; and a membrane filter portion downstream of the prefilter portion, the membrane filter portion having a pore size distribution having a median pore size between 3 and 12 microns and having at least 40% of the pore volume being constituted by pores having a pore cross section diameter of between 3 and 10 microns and having at least 5% of the pore volume being constitutted by pores having a pore cross section diameter larger than 10 microns. In a preferred embodiment, no more than 60% of the pore volume is constituted by pores having a pore cross section diameter larger than 10 microns. In another preferred embodiment, the membrane filter portion is characterized in that no more than 30% of the pore volume is constituted by pores having a pore cross section diameter less than 3 microns.
    Type: Application
    Filed: September 26, 2003
    Publication date: March 25, 2004
    Applicant: TEVA MEDICAL LTD.
    Inventors: Menachem Kraus, Yefet Gamlieli
  • Publication number: 20030189003
    Abstract: A filter unit for removing leukocytes from a leukocyte-containing suspension by passing the suspension through a filter unit. The filter unit may comprise a main filter for blocking the leukocytes and a post-filter for preventing leakage of the leukocytes having a higher median pore size than the main filter and placed downstream of the main-filter.
    Type: Application
    Filed: April 8, 2002
    Publication date: October 9, 2003
    Inventors: Menahem Kraus, Yefet Gamlieli
  • Patent number: 6629613
    Abstract: There is provided a leukocyte filter comprising: a prefilter portion; and a membrane filter portion downstream of the prefilter portion, the membrane filter portion having a pore size distribution having a median pore size between 3 and 12 microns and having at least 40% of the pore volume being constituted by pores having a pore cross section diameter of between 3 and 10 microns and having at least 5% of the pore volume being constituted by pores having a pore cross section diameter larger than 10 microns. In a preferred embodiment, no more than 60% of the pore volume is constituted by pores having a pore cross section diameter larger than 10 microns. In another preferred embodiment, the membrane filter portion is characterized in that no more than 30% of the pore volume is constituted by pores having a pore cross section diameter less than 3 microns.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: October 7, 2003
    Assignee: Teva Medical Ltd.
    Inventors: Menachem Kraus, Yefet Gamlieli